Background
Methods
Study population
Mammography behaviour
Sociodemographic and breast cancer risk factor data
Clinical data
Passive follow-up
Exclusions
Statistical analysis
Results
Population description
n (%) | Total, n = 3739 | Screeners, n = 1089 (29.1) | Non-screeners, n = 2260 (60.4) | Unaware, n = 390 (10.4) | P |
---|---|---|---|---|---|
Site, n (%) | |||||
CGH | 377 (10.1) | 79 (7.3) | 239 (10.6) | 59 (15.1) | <0.001 |
KKH | 724 (19.4) | 173 (15.9) | 476 (21.1) | 75 (19.2) | |
NCC | 704 (18.8) | 260 (23.9) | 391 (17.3) | 53 (13.6) | |
NTFGH | 32 (0.9) | 7 (0.6) | 23 (1.0) | 2 (0.5) | |
NUH | 630 (16.8) | 164 (15.1) | 398 (17.6) | 68 (17.4) | |
SGH | 318 (8.5) | 107 (9.8) | 185 (8.2) | 26 (6.7) | |
TTSH | 954 (25.5) | 299 (27.5) | 548 (24.2) | 107 (27.4) | |
Sociodemographic factors | |||||
Age at diagnosis (years, IQR) | |||||
60.0 (55.0–66.0) | 58.0 (54.0–64.0) | 60.0 (55.0–66.0) | 66.0 (59.0–73.0) | <0.001 | |
Age at diagnosis (categorical), n (%) | |||||
50–59 | 1800 (48.1) | 610 (56.0) | 1084 (48.0) | 106 (27.2) | <0.001 |
≥60 | 1939 (51.9) | 479 (44.0) | 1176 (52.0) | 284 (72.8) | |
Ethnicity, n (%) | |||||
Chinese | 3000 (80.2) | 888 (81.5) | 1797 (79.5) | 315 (80.8) | 0.016 |
Malay | 431 (11.5) | 99 (9.1) | 281 (12.4) | 51 (13.1) | |
Indian | 215 (5.8) | 72 (6.6) | 122 (5.4) | 21 (5.4) | |
Others | 93 (2.5) | 30 (2.8) | 60 (2.7) | 3 (0.8) | |
Highest qualification attained, n (%) | |||||
No formal/primary | 1358 (36.3) | 241 (22.1) | 837 (37.0) | 280 (71.8) | <0.001 |
Secondary | 1651 (44.2) | 545 (50.0) | 1013 (44.8) | 93 (23.8) | |
Post-secondary (non-tertiary) | 202 (5.4) | 84 (7.7) | 114 (5.0) | 4 (1.0) | |
Professional diploma | 183 (4.9) | 93 (8.5) | 88 (3.9) | 2 (0.5) | |
Tertiary | 227 (6.1) | 94 (8.6) | 131 (5.8) | 2 (0.5) | |
Missing | 118 (3.2) | 32 (2.9) | 77 (3.4) | 9 (2.3) | |
Housing, n (%) | |||||
HDB 1–3 rooms | 912 (24.4) | 192 (17.6) | 566 (25.0) | 154 (39.5) | <0.001 |
HDB >3 rooms | 2308 (61.7) | 694 (63.7) | 1408 (62.3) | 206 (52.8) | |
Private | 462 (12.4) | 193 (17.7) | 247 (10.9) | 22 (5.6) | |
Other/missing | 57 (1.5) | 10 (0.9) | 39 (1.7) | 8 (2.1) | |
Marital status, n (%) | |||||
Married | 2651 (70.9) | 828 (76.0) | 1595 (70.6) | 228 (58.5) | <0.001 |
Never married | 469 (12.5) | 126 (11.6) | 299 (13.2) | 44 (11.3) | |
Widowed | 421 (11.3) | 84 (7.7) | 244 (10.8) | 93 (23.8) | |
Separated or divorced | 198 (5.3) | 51 (4.7) | 122 (5.4) | 25 (6.4) | |
Lifestyle risk factors | |||||
Smoking, n (%) | |||||
No | 3611 (96.6) | 1063 (97.6) | 2179 (96.4) | 369 (94.6) | 0.016 |
Yes | 128 (3.4) | 26 (2.4) | 81 (3.6) | 21 (5.4) | |
Alcohol, n (%) | |||||
No | 3633 (97.2) | 1055 (96.9) | 2194 (97.1) | 384 (98.5) | 0.251 |
Yes | 106 (2.8) | 34 (3.1) | 66 (2.9) | 6 (1.5) | |
Physical activity between ages 18 and 30 years, n (%) | |||||
1 | 264 (7.1) | 70 (6.4) | 158 (7.0) | 36 (9.2) | <0.001 |
2 | 2517 (67.3) | 673 (61.8) | 1541 (68.2) | 303 (77.7) | |
3 | 210 (5.6) | 78 (7.2) | 126 (5.6) | 6 (1.5) | |
4 | 455 (12.2) | 146 (13.4) | 279 (12.3) | 30 (7.7) | |
5 | 293 (7.8) | 122 (11.2) | 156 (6.9) | 15 (3.8) | |
Medical risk factors | |||||
Charlson comorbidity index, n (%) | |||||
0 | 2549 (68.2) | 780 (71.6) | 1552 (68.7) | 217 (55.6) | <0.001 |
1 | 852 (22.8) | 216 (19.8) | 520 (23.0) | 116 (29.7) | |
>1 | 334 (8.9) | 93 (8.5) | 184 (8.1) | 57 (14.6) | |
Missing | 4 (0.1) | 0 (0.0) | 4 (0.2) | 0 (0.0) | |
Previous surgery for benign lump, n (%) | |||||
No | 3301 (88.3) | 896 (82.3) | 2038 (90.2) | 367 (94.1) | <0.001 |
Yes | 435 (11.6) | 193 (17.7) | 221 (9.8) | 21 (5.4) | |
Missing | 3 (0.1) | 0 (0.0) | 1 (0.0) | 2 (0.5) | |
Previous gynaecological surgery, n (%) | |||||
No | 2302 (61.6) | 632 (58.0) | 1414 (62.6) | 256 (65.6) | 0.007 |
Yes | 1431 (38.3) | 456 (41.9) | 844 (37.3) | 131 (33.6) | |
Missing | 6 (0.2) | 1 (0.1) | 2 (0.1) | 3 (0.8) | |
Family history of breast cancer, n (%) | |||||
No | 2759 (73.8) | 760 (69.8) | 1687 (74.6) | 312 (80.0) | <0.001 |
Yes | 837 (22.4) | 294 (27.0) | 482 (21.3) | 61 (15.6) | |
Missing | 143 (3.8) | 35 (3.2) | 91 (4.0) | 17 (4.4) | |
Family history of ovarian cancer, n (%) | |||||
No | 3477 (93.0) | 1017 (93.4) | 2101 (93.0) | 359 (92.1) | 0.797 |
Yes | 107 (2.9) | 32 (2.9) | 62 (2.7) | 13 (3.3) | |
Missing | 155 (4.1) | 40 (3.7) | 97 (4.3) | 18 (4.6) | |
Reproductive risk factors | |||||
Age at first full-term pregnancy, n (%) | |||||
Nulliparous | 725 (19.4) | 200 (18.4) | 462 (20.4) | 63 (16.2) | <0.001 |
<20 | 217 (5.8) | 45 (4.1) | 118 (5.2) | 54 (13.8) | |
20–24 | 808 (21.6) | 209 (19.2) | 497 (22.0) | 102 (26.2) | |
25–29 | 1113 (29.8) | 349 (32.0) | 661 (29.2) | 103 (26.4) | |
>30 | 853 (22.8) | 283 (26.0) | 510 (22.6) | 60 (15.4) | |
Missing | 23 (0.6) | 3 (0.3) | 12 (0.5) | 8 (2.1) | |
Parity, n (%) | |||||
0 | 725 (19.4) | 200 (18.4) | 462 (20.4) | 63 (16.2) | <0.001 |
1 | 459 (12.3) | 126 (11.6) | 295 (13.1) | 38 (9.7) | |
2 | 1296 (34.7) | 442 (40.6) | 762 (33.7) | 92 (23.6) | |
≥3 | 1258 (33.6) | 321 (29.5) | 741 (32.8) | 196 (50.3) | |
Missing | 1 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.3) | |
Infertility treatment, n (%) | |||||
No | 3590 (96.0) | 1028 (94.4) | 2178 (96.4) | 384 (98.5) | <0.001 |
Yes | 149 (4.0) | 61 (5.6) | 82 (3.6) | 6 (1.5) | |
Oral contraception, n (%) | |||||
No | 2813 (75.2) | 818 (75.1) | 1698 (75.1) | 297 (76.2) | 0.906 |
Yes | 926 (24.8) | 271 (24.9) | 562 (24.9) | 93 (23.8) | |
Hormone replacement treatment, n (%) | |||||
Never | 3309 (88.5) | 918 (84.3) | 2018 (89.3) | 373 (95.6) | <0.001 |
Ever | 401 (10.7) | 161 (14.8) | 227 (10.0) | 13 (3.3) | |
Missing | 29 (0.8) | 10 (0.9) | 15 (0.7) | 4 (1.0) | |
Menopausal status at diagnosis, n (%) | |||||
Post-menopausal | 3084 (82.5) | 845 (77.6) | 1885 (83.4) | 354 (90.8) | <0.001 |
Pre-menopausal | 655 (17.5) | 244 (22.4) | 375 (16.6) | 36 (9.2) |
Mammography screening attendance is associated with more favourable breast cancer tumour characteristics at diagnosis
Screeners, n=1089 | Non-screeners, n=2260 | Unaware, n=390 | ||||||
---|---|---|---|---|---|---|---|---|
N | N | OR (95% CI) | P | N | OR (95% CI) | P | ||
Stage | ||||||||
I | 521 | 1.00 (reference) | 694 | 90 | ||||
II | 437 | 1011 | 1.72 (1.46–2.02) | <0.001 | 194 | 2.72 (2.02–3.65) | <0.001 | |
III | 131 | 555 | 3.17 (2.52–3.98) | <0.001 | 106 | 4.94 (3.45–7.07) | <0.001 | |
Grade | ||||||||
Well-differentiated | 190 | 1.00 (reference) | 284 | 59 | ||||
Moderately differentiated | 451 | 949 | 1.41 (1.13–1.76) | 0.002 | 149 | 1.15 (0.80–1.65) | 0.461 | |
Poorly differentiated | 413 | 941 | 1.58 (1.26–1.97) | <0.001 | 160 | 1.53 (1.06–2.20) | 0.022 | |
Missing | 35 | 86 | 22 | |||||
Nodal status | ||||||||
Negative | 739 | 1.00 (reference) | 1269 | 208 | ||||
Positive | 345 | 959 | 1.61 (1.38–1.89) | <0.001 | 180 | 1.96 (1.52–2.52) | <0.001 | |
Missing | 5 | 32 | 2 | |||||
Tumour size | ||||||||
≤2cm | 643 | 1.00 (reference) | 947 | 133 | ||||
>2–≤5cm | 389 | 1037 | 1.73 (1.48–2.03) | <0.001 | 204 | 2.43 (1.86–3.16) | <0.001 | |
>5cm | 40 | 205 | 3.22 (2.25–4.61) | <0.001 | 44 | 5.06 (3.10–8.25) | <0.001 | |
Missing | 17 | 71 | 9 | |||||
Oestrogen receptor status | ||||||||
Positive | 775 | 1.00 (reference) | 1538 | 277 | ||||
Negative | 231 | 514 | 1.12 (0.93–1.34) | 0.225 | 85 | 1.10 (0.82–1.48) | 0.516 | |
Missing | 83 | 208 | 28 | |||||
Progesterone receptor status | ||||||||
Positive | 642 | 1.00 (reference) | 1316 | 247 | ||||
Negative | 364 | 727 | 1.00 (0.85–1.17) | 0.989 | 116 | 0.92 (0.70–1.20) | 0.54 | |
Missing | 83 | 217 | 27 | |||||
HER2 status | ||||||||
Positive | 236 | 1.00 (reference) | 540 | 89 | ||||
Negative | 714 | 1415 | 0.80 (0.67–0.96) | 0.016 | 252 | 0.72 (0.53–0.97) | 0.028 | |
Missing | 139 | 305 | 49 | |||||
Subtype | ||||||||
Luminal A | 445 | 1.00 (reference) | 880 | 156 | ||||
Luminal B [HER2-negative] | 159 | 354 | 1.15 (0.92–1.44) | 0.206 | 69 | 1.44 (1.01–2.05) | 0.041 | |
Luminal B [HER2-positive] | 8 | 22 | 1.48 (0.65–3.38) | 0.352 | 6 | 2.53 (0.81–7.84) | 0.109 | |
HER2-overexpressed | 86 | 219 | 1.39 (1.05–1.83) | 0.022 | 31 | 1.40 (0.88–2.23) | 0.158 | |
Triple negative | 107 | 204 | 0.96 (0.74–1.25) | 0.754 | 39 | 1.12 (0.73–1.72) | 0.607 | |
Missing | 284 | 581 | 89 |
Mammography screening attendance is associated with more favourable overall cancer survival
Univariate | Adjusted model 1 | Adjusted model 2 | Adjusted model 3 | |||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Mammography behaviour | ||||||||
Screeners | 1.00 (reference) | |||||||
Non-screeners | 1.89 (1.22–2.94) | 0.005 | 1.77 (1.12–2.77) | 0.014 | 1.48 (0.94–2.31) | 0.088 | 1.44 (0.92–2.25) | 0.113 |
Unaware | 2.90 (1.69–4.98) | <0.001 | 1.80 (0.99–3.27) | 0.054 | 1.58 (0.89–2.79) | 0.118 | 1.58 (0.89–2.79) | 0.118 |
Screening attendees tend to be younger, received higher education, and have had a family history of breast cancer
Screeners, n=1089 | Non-screeners, n=2260 | Unaware, n=390 | ||||||
---|---|---|---|---|---|---|---|---|
N | N | OR (95% CI) | P | N | OR (95% CI) | P | ||
Sociodemographic factors | ||||||||
Age at diagnosis (categorical) | ||||||||
50–59 | 610 | 1.00 (reference) | 1084 | 106 | ||||
≥60 | 479 | 1176 | 1.36 (1.18–1.58) | <0.001 | 284 | 3.60 (2.79–4.66) | <0.001 | |
Ethnicity | ||||||||
Chinese | 888 | 1.00 (reference) | 1797 | 315 | ||||
Malay | 99 | 281 | 1.42 (1.11–1.82) | 0.005 | 51 | 1.89 (1.29–2.77) | 0.001 | |
Indian | 72 | 122 | 0.85 (0.62–1.15) | 0.285 | 21 | 0.97 (0.58–1.63) | 0.906 | |
Others | 30 | 60 | 0.94 (0.60–1.48) | 0.79 | 3 | 0.24 (0.07–0.83) | 0.024 | |
Highest qualification attained | ||||||||
No formal/primary | 241 | 837 | 1.76 (1.46–2.11) | <0.001 | 280 | 5.04 (3.77–6.75) | <0.001 | |
Secondary | 545 | 1.00 (reference) | 1013 | 93 | ||||
Post-secondary (non-tertiary) | 84 | 114 | 0.75 (0.55–1.01) | 0.062 | 4 | 0.30 (0.11–0.83) | 0.021 | |
Professional diploma | 93 | 88 | 0.51 (0.37–0.70) | <0.001 | 2 | 0.15 (0.04–0.63) | 0.01 | |
Tertiary | 94 | 131 | 0.75 (0.56–1.00) | 0.053 | 2 | 0.14 (0.03–0.58) | 0.007 | |
Missing | 32 | 77 | 9 | |||||
Housing | ||||||||
HDB 1–3 rooms | 192 | 566 | 1.43 (1.18–1.73) | <0.001 | 154 | 2.33 (1.77–3.07) | <0.001 | |
HDB >3 rooms | 694 | 1.00 (reference) | 1408 | 206 | ||||
Private | 193 | 247 | 0.60 (0.48–0.74) | <0.001 | 22 | 0.28 (0.17–0.45) | <0.001 | |
Others/missing | 10 | 39 | 8 | |||||
Marital status | ||||||||
Married | 828 | 1.00 (reference) | 1595 | 228 | ||||
Never married | 126 | 299 | 1.25 (0.99–1.57) | 0.057 | 44 | 1.18 (0.80–1.73) | 0.41 | |
Widowed | 84 | 244 | 1.26 (0.95–1.67) | 0.106 | 93 | 1.85 (1.28–2.69) | 0.001 | |
Separated/divorced | 51 | 122 | 1.22 (0.86–1.71) | 0.261 | 25 | 1.57 (0.93–2.65) | 0.09 | |
Lifestyle risk factors | ||||||||
Smoking | ||||||||
No | 1063 | 1.00 (reference) | 2179 | 369 | ||||
Yes | 26 | 81 | 1.59 (1.01–2.50) | 0.045 | 21 | 2.85 (1.53–5.32) | <0.001 | |
Alcohol | ||||||||
No | 1055 | 1.00 (reference) | 2194 | 384 | ||||
Yes | 34 | 66 | 1.00 (0.66–1.53) | 0.99 | 6 | 0.63 (0.26–1.55) | 0.313 | |
Physical activity between 18 and 30 | ||||||||
1 | 70 | 158 | 0.90 (0.65–1.25) | 0.543 | 36 | 0.80 (0.48–1.33) | 0.397 | |
2 | 673 | 1.00 (reference) | 1541 | 303 | ||||
3 | 78 | 126 | 0.75 (0.55–1.02) | 0.068 | 6 | 0.17 (0.07–0.42) | <0.001 | |
4 | 146 | 279 | 0.89 (0.71–1.11) | 0.302 | 30 | 0.49 (0.32–0.76) | 0.001 | |
5 | 122 | 156 | 0.52 (0.40–0.68) | <0.001 | 15 | 0.30 (0.17–0.53) | <0.001 | |
Medical risk factors | ||||||||
Charlson comorbidity index | ||||||||
0 | 780 | 1.00 (reference) | 1552 | 217 | ||||
1 | 216 | 520 | 1.14 (0.95–1.38) | 0.154 | 116 | 1.48 (1.11–1.97) | 0.007 | |
>1 | 93 | 184 | 0.94 (0.71–1.22) | 0.626 | 57 | 1.57 (1.07–2.31) | 0.021 | |
Missing | 0 | 4 | 0 | |||||
Previous surgery for benign lump | ||||||||
No | 896 | 1.00 (reference) | 2038 | 367 | ||||
Yes | 193 | 221 | 0.50 (0.41–0.62) | <0.001 | 21 | 0.28 (0.17–0.45) | <0.001 | |
Missing | 0 | 1 | 2 | |||||
Previous gynaecological surgery | ||||||||
No | 632 | 1.00 (reference) | 1414 | 256 | ||||
Yes | 456 | 844 | 0.79 (0.68–0.92) | 0.002 | 131 | 0.64 (0.50–0.83) | <0.001 | |
Missing | 1 | 2 | 3 | |||||
Family history of breast cancer | ||||||||
No | 760 | 1.00 (reference) | 1687 | 312 | ||||
Yes | 294 | 482 | 0.74 (0.62–0.87) | <0.001 | 61 | 0.54 (0.39–0.74) | <0.001 | |
Missing | 35 | 91 | 17 | |||||
Family history of ovarian cancer | ||||||||
No | 1017 | 1.00 (reference) | 2101 | 359 | ||||
Yes | 32 | 62 | 0.98 (0.63–1.52) | 0.918 | 13 | 1.37 (0.69–2.72) | 0.369 | |
Missing | 40 | 97 | 18 | |||||
Reproductive risk factors | ||||||||
Age at first full-term pregnancy | ||||||||
Nulliparous | 200 | 462 | 1.27 (1.03–1.57) | 0.028 | 63 | 1.18 (0.81–1.71) | 0.387 | |
<20 | 45 | 118 | 1.31 (0.90–1.90) | 0.153 | 54 | 3.19 (1.98–5.13) | <0.001 | |
20–24 | 209 | 497 | 1.20 (0.97–1.49) | 0.085 | 102 | 1.42 (1.01–1.99) | 0.042 | |
25–29 | 349 | 1.00 (reference) | 661 | 103 | ||||
>30 | 283 | 510 | 0.99 (0.81–1.20) | 0.908 | 60 | 0.86 (0.59–1.24) | 0.411 | |
Missing | 3 | 12 | 8 | |||||
Parity | ||||||||
0 | 200 | 462 | 1.37 (1.11–1.68) | 0.003 | 63 | 1.45 (1.00–2.11) | 0.049 | |
1 | 126 | 295 | 1.39 (1.09–1.77) | 0.008 | 38 | 1.40 (0.90–2.17) | 0.136 | |
2 | 442 | 1.00 (reference) | 762 | 92 | ||||
≥3 | 321 | 741 | 1.25 (1.04–1.50) | 0.015 | 196 | 2.06 (1.52–2.78) | <0.001 | |
Missing | 0 | 0 | 1 | |||||
Infertility treatment | ||||||||
No | 1028 | 1.00 (reference) | 2178 | 384 | ||||
Yes | 61 | 82 | 0.72 (0.51–1.02) | 0.068 | 6 | 0.47 (0.20–1.10) | 0.083 | |
Oral contraception | ||||||||
No | 818 | 1.00 (reference) | 1698 | 297 | ||||
Yes | 271 | 562 | 0.98 (0.82–1.16) | 0.781 | 93 | 0.82 (0.62–1.10) | 0.185 | |
Hormone replacement treatment | ||||||||
Never | 918 | 1.00 (reference) | 2018 | 373 | ||||
Ever | 161 | 227 | 0.59 (0.47–0.74) | <0.001 | 13 | 0.14 (0.08–0.26) | <0.001 | |
Missing | 10 | 15 | 4 | |||||
Menopausal status at diagnosis | ||||||||
Post-menopausal | 845 | 1.00 (reference) | 1885 | 354 | ||||
Pre-menopausal | 244 | 375 | 0.94 (0.76–1.17) | 0.608 | 36 | 1.27 (0.82–1.95) | 0.287 |
Deterrents and motivators of mammography attendance
Not motivated by cues to action, n=483 | Motivated by cues to action, n=606 | Univariate | Adjusted | |||
---|---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |||
Site | ||||||
CGH | 59 | 20 | 1.00 (reference) | |||
KKH | 85 | 88 | 3.05 (1.70–5.50) | <0.001 | 1.28 (0.64–2.58) | 0.487 |
NCC | 80 | 180 | 6.64 (3.75–11.75) | <0.001 | 5.10 (2.68–9.73) | <0.001 |
NTFGH | 5 | 2 | 1.18 (0.21–6.57) | 0.85 | 0.90 (0.13–6.03) | 0.914 |
NUH | 111 | 53 | 1.41 (0.77–2.58) | 0.266 | 0.83 (0.41–1.68) | 0.6 |
SGH | 48 | 59 | 3.63 (1.92–6.84) | <0.001 | 1.82 (0.86–3.85) | 0.119 |
TTSH | 95 | 204 | 6.34 (3.61–11.12) | <0.001 | 4.06 (2.15–7.67) | <0.001 |
Health consciousness | ||||||
0 | 92 | 330 | 1.00 (reference) | |||
1 | 391 | 276 | 0.20 (0.15–0.26) | <0.001 | 0.16 (0.11–0.22) | <0.001 |
Sociodemographic factors | ||||||
Age at diagnosis (categorical) | ||||||
50–59 | 294 | 316 | 1.00 (reference) | |||
≥60 | 189 | 290 | 1.43 (1.12–1.82) | 0.004 | 1.28 (0.92–1.77) | 0.141 |
Ethnicity | ||||||
Chinese | 382 | 506 | 1.00 (reference) | |||
Malay | 52 | 47 | 0.68 (0.45–1.03) | 0.072 | ||
Indian | 37 | 35 | 0.71 (0.44–1.16) | 0.17 | ||
Others | 12 | 18 | 1.13 (0.54–2.38) | 0.743 | ||
Highest qualification attained | ||||||
No formal/primary | 78 | 163 | 1.67 (1.21–2.29) | 0.002 | 1.15 (0.78–1.70) | 0.471 |
Secondary | 242 | 303 | 1.00 (reference) | |||
Post-secondary (non-tertiary) | 34 | 50 | 1.17 (0.74–1.87) | 0.5 | 1.27 (0.73–2.20) | 0.39 |
Professional diploma | 60 | 33 | 0.44 (0.28–0.69) | <0.001 | 0.59 (0.35–1.01) | 0.054 |
Tertiary | 54 | 40 | 0.59 (0.38–0.92) | 0.02 | 0.86 (0.50–1.47) | 0.576 |
Missing | 15 | 17 | ||||
Housing | ||||||
HDB 1–3 rooms | 66 | 126 | 1.48 (1.06–2.06) | 0.021 | 1.09 (0.73–1.64) | 0.663 |
HDB >3 rooms | 303 | 391 | 1.00 (reference) | |||
Private | 109 | 84 | 0.60 (0.43–0.82) | 0.002 | 0.80 (0.54–1.19) | 0.271 |
Others/missing | 5 | 5 | ||||
Marital status | ||||||
Married | 379 | 449 | 1.00 (reference) | |||
Never married | 62 | 64 | 0.87 (0.60–1.27) | 0.472 | 1.05 (0.54–2.04) | 0.887 |
Widowed | 27 | 57 | 1.78 (1.11–2.87) | 0.018 | 1.25 (0.72–2.17) | 0.426 |
Separated/divorced | 15 | 36 | 2.03 (1.09–3.76) | 0.025 | 2.07 (0.98–4.35) | 0.056 |
Lifestyle risk factors | ||||||
Smoking | ||||||
No | 470 | 593 | 1.00 (reference) | |||
Yes | 13 | 13 | 0.79 (0.36–1.73) | 0.559 | ||
Alcohol | ||||||
No | 468 | 587 | 1.00 (reference) | |||
Yes | 15 | 19 | 1.01 (0.51–2.01) | 0.978 | ||
Physical activity between 18 and 30 | ||||||
1 | 32 | 38 | 0.82 (0.50–1.35) | 0.433 | 1.15 (0.61–2.18) | 0.664 |
2 | 275 | 398 | 1.00 (reference) | |||
3 | 40 | 38 | 0.66 (0.41–1.05) | 0.079 | 0.58 (0.33–1.03) | 0.062 |
4 | 64 | 82 | 0.89 (0.62–1.27) | 0.509 | 0.99 (0.65–1.52) | 0.972 |
5 | 72 | 50 | 0.48 (0.32–0.71) | <0.001 | 0.70 (0.44–1.12) | 0.135 |
Medical risk factors | ||||||
Charlson comorbidity index | ||||||
0 | 354 | 426 | 1.00 (reference) | |||
1 | 96 | 120 | 1.04 (0.77–1.41) | 0.806 | ||
>1 | 33 | 60 | 1.51 (0.97–2.36) | 0.071 | ||
Previous surgery for benign lump | ||||||
No | 394 | 502 | 1.00 (reference) | |||
Yes | 89 | 104 | 0.92 (0.67–1.25) | 0.587 | ||
Previous gynaecological surgery | ||||||
No | 291 | 341 | 1.00 (reference) | |||
Yes | 192 | 264 | 1.17 (0.92–1.50) | 0.198 | ||
Missing | 0 | 1 | ||||
Family history of breast cancer | ||||||
No | 336 | 424 | 1.00 (reference) | |||
Yes | 135 | 159 | 0.93 (0.71–1.22) | 0.617 | ||
Missing | 12 | 23 | ||||
Family history of ovarian cancer | ||||||
No | 458 | 559 | 1.00 (reference) | |||
Yes | 12 | 20 | 1.37 (0.66–2.82) | 0.401 | ||
Missing | 13 | 27 | ||||
Reproductive risk factors | ||||||
Age at first full-term pregnancy | ||||||
Nulliparous | 99 | 101 | 0.79 (0.56–1.12) | 0.179 | 0.89 (0.66–1.21) | 0.467 |
<20 | 10 | 35 | 2.70 (1.30–5.63) | 0.008 | 1.82 (0.77–4.30) | 0.174 |
20–24 | 93 | 116 | 0.96 (0.68–1.36) | 0.828 | 0.65 (0.43–1.00) | 0.048 |
25–29 | 152 | 197 | 1.00 (reference) | |||
>30 | 127 | 156 | 0.95 (0.69–1.30) | 0.739 | 1.00 (0.68–1.47) | 0.986 |
Missing | 2 | 1 | ||||
Parity | ||||||
0 | 99 | 101 | 0.92 (0.66–1.29) | 0.64 | 0.89 (0.66–1.21) | 0.467 |
1 | 54 | 72 | 1.21 (0.81–1.80) | 0.356 | 1.04 (0.65–1.68) | 0.863 |
2 | 210 | 232 | 1.00 (reference) | |||
≥3 | 120 | 201 | 1.52 (1.13–2.03) | 0.005 | 1.04 (0.72–1.49) | 0.847 |
Infertility treatment | ||||||
No | 455 | 573 | 1.00 (reference) | |||
Yes | 28 | 33 | 0.94 (0.56–1.57) | 0.802 | ||
Oral contraception | ||||||
No | 384 | 434 | 1.00 (reference) | |||
Yes | 99 | 172 | 1.54 (1.16–2.04) | 0.003 | 1.25 (0.88–1.77) | 0.218 |
Hormone replacement treatment | ||||||
Never | 412 | 506 | 1.00 (reference) | |||
Ever | 67 | 94 | 1.14 (0.81–1.60) | 0.442 | ||
Missing | 4 | 6 | ||||
Menopausal status at diagnosis | ||||||
Post-menopausal | 355 | 490 | 1.00 (reference) | |||
Pre-menopausal | 128 | 116 | 0.66 (0.49–0.87) | 0.004 | 0.76 (0.52–1.12) | 0.166 |